Seeking Alpha

LPTN.OB
Lpath Inc.

5/26/2012, 12:12 PM ET
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
LPTN.OB Market Currents more »
  • January 27 Shares of Lpath (LPTN.OB -31.8%) plummet after the biotech company temporarily suspends trials for its PEDigree and Nexus lipidomics-based antibody therapeutics. LPTN says it took the action when it learned its fill/finish contractor was not in FDA compliance for manufacturing requirements. (submitted by M.E. Garza)
    Comment!
    [Healthcare, On the Move]
LPTN.OB in Focus more »
LPTN.OB News more »
Currently, there are no news on LPTN.OB.
LPTN.OB Press Releases and Filings more »
Currently, there are no press releases or filings on LPTN.OB.
LPTN.OB Latest Transcript more »
Currently, there are no transcripts for LPTN.OB.
LPTN.OB Cramer more »
Currently, there are no Cramer articles on LPTN.OB.
LPTN.OB Instablog posts more »
  • Lpath Inc. (LPTN) Adds Two Patents to Growing Portfolio of Antibody Therapeutics
    Wed, Oct 5, 2011 • QualityStocks • Comment!
  • Lpath Inc. (LPTN.OB) Receives Key Patents from U.S. and European Patent Offices
    Fri, Feb 4, 2011 • QualityStocks • Comment!
  • LPath, Inc. (LPTN.OB) Receives $3 Million Grant from the National Eye Institute BRDG-SPAN Program
    Fri, Jul 30, 2010 • QualityStocks • Comment!
  • Will LPATH (LPTN.OB) Reap the Fruits Of Its Acknowledged Efforts
    Wed, Mar 31, 2010 • Prohost Biotech • 1 Comment
Write a post on LPTN.OB
LPTN.OB StockTalks
LPTN.OB vs. ETF Alternatives
Company Description
Currently, there's no company description for LPTN.OB.
Sector: Healthcare
Industry: Biotechnology
Country: United States